Researchers in Australia have found that when women are given accurate information about a test that indicates the number of eggs in their ovaries, they have less interest in taking the test compared to women who viewed information available online.
The researchers initiated the study, which is published in the journal Human Reproduction, because of the large amount of misleading and incorrect information promoted to women about the anti-Mullerian hormone (AMH) test on websites, including fertility clinic websites, and via social media.
AMH is measured by a blood test that is considered to give an indication of the number of eggs available in the ovaries of adult women, but not of the quality of these eggs. The test can be helpful in fertility treatment as it indicates the approximate number of eggs that can be retrieved for in vitro fertilization (IVF) or egg freezing, but it cannot reliably predict the chances of conceiving or the specific age of menopause for individual women.
For this reason, the American College of Obstetricians and Gynecologists strongly discourages AMH testing for women not seeking fertility treatment. However, Dr. Tessa Copp, a post-doctoral research fellow at the School of Public Health, the University of Sydney, Australia, and other researchers have found that the AMH test is being promoted increasingly as a way for women to find out about their fertility and when they will go through menopause.
Dr. Copp said, "Companies, including some...
“The mere fact that Ms Lively feels that she can publicly destroy Mr Baldoni’s reputation in an attempt to devastate his future career and then deny him or his team their own ability to defend [th...